Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.
http://www.has-sante.fr/portail/jcms/c_1294158/revatio-par-voie-orale-sildenafil-inhibiteur-de-la-phosphodiesterase http://www.has-sante.fr/portail/jcms/c_1294059/revatio-orale-synthese-06062012 http://www.has-sante.fr/portail/jcms/c_1262534/revatio-06062012-avis-ct12241 2012 false France French evaluation of the transparency committee guidelines for drug use Sildenafil Citrate Sildenafil Citrate administration, oral phosphodiesterase inhibitors phosphodiesterase inhibitors pharmaceutical solutions child hypertension, pulmonary adolescent heart defects, congenital treatment outcome orphan drug production tablets clinical trials as topic survival analysis
--- http://www.has-sante.fr/portail/jcms/c_1294155/revatio-par-voie-intraveineuse-sildenafil-inhibiteur-de-la-phosphodiesterase http://www.has-sante.fr/portail/jcms/c_1294055/revatio-injectable-synthese-16112011 http://www.has-sante.fr/portail/jcms/c_1247949/revatio-16112011-avis-ct11475 2011 false France French guidelines for drug use Sildenafil Citrate evaluation of the transparency committee phosphodiesterase inhibitors insurance, health, reimbursement treatment outcome hypertension, pulmonary injections, intravenous orphan drug production adult aged